These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34064754)

  • 1. Phage Therapy in Livestock and Companion Animals.
    Ferriol-González C; Domingo-Calap P
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34064754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vets' and Pet Owners' Views About Antibiotics for Companion Animals and the Use of Phages as an Alternative.
    Rhys-Davies L; Ogden J
    Front Vet Sci; 2020; 7():513770. PubMed ID: 33134344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial-resistant Enterobacteriaceae recovered from companion animal and livestock environments.
    Adams RJ; Kim SS; Mollenkopf DF; Mathys DA; Schuenemann GM; Daniels JB; Wittum TE
    Zoonoses Public Health; 2018 Aug; 65(5):519-527. PubMed ID: 29575700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Phage Therapies in Companion Animals with A Historical Review.
    Pyzik E; Radzki RP; Urban-Chmiel R
    Curr Rev Clin Exp Pharmacol; 2021; 16(1):17-29. PubMed ID: 32223736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens.
    Sweeney MT; Lubbers BV; Schwarz S; Watts JL
    J Antimicrob Chemother; 2018 Jun; 73(6):1460-1463. PubMed ID: 29481657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
    Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
    Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant pathogens in the food supply.
    Doyle ME
    Foodborne Pathog Dis; 2015 Apr; 12(4):261-79. PubMed ID: 25621383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.
    Taati Moghadam M; Amirmozafari N; Shariati A; Hallajzadeh M; Mirkalantari S; Khoshbayan A; Masjedian Jazi F
    Infect Drug Resist; 2020; 13():45-61. PubMed ID: 32021319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy as a glimmer of hope in the fight against the recurrence or emergence of surgical site bacterial infections.
    Moghadam MT; Mojtahedi A; Salamy S; Shahbazi R; Satarzadeh N; Delavar M; Ashoobi MT
    Infection; 2024 Apr; 52(2):385-402. PubMed ID: 38308075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current state of phage therapy in livestock and companion animals.
    Choi Y; Lee W; Kwon JG; Kang A; Kwak MJ; Eor JY; Kim Y
    J Anim Sci Technol; 2024 Jan; 66(1):57-78. PubMed ID: 38618037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment.
    Chung KM; Liau XL; Tang SS
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design combinations of evolved phage and antibiotic for antibacterial guided by analyzing the phage resistance of poorly antimicrobial phage.
    Xu Z; Ding Z; Shi L; Xie Y; Zhang Y; Sao S; Wang Q; Liu Q
    Microbiol Spectr; 2023 Sep; 11(5):e0095823. PubMed ID: 37707457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Phages to Treat Antimicrobial-Resistant
    Khan MAS; Rahman SR
    Vet Sci; 2022 Aug; 9(8):. PubMed ID: 36006353
    [No Abstract]   [Full Text] [Related]  

  • 20. Public health risk of antimicrobial resistance transfer from companion animals.
    Pomba C; Rantala M; Greko C; Baptiste KE; Catry B; van Duijkeren E; Mateus A; Moreno MA; Pyörälä S; Ružauskas M; Sanders P; Teale C; Threlfall EJ; Kunsagi Z; Torren-Edo J; Jukes H; Törneke K
    J Antimicrob Chemother; 2017 Apr; 72(4):957-968. PubMed ID: 27999066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.